Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00324948

Topical Alprostadil for Female Sexual Arousal Disorder

Sexual Dysfunction, Physiological Clinical Trial

Official title:
A Double-Blind, Randomized, 6-Month Evaluation of the Safety and Efficacy of Topical Alprostadil in Hysterectomized Women With Female Sexual Arousal Disorder (FSAD)

Clinical Trial Summary

Approximately 300 patients with female sexual arousal disorder who meet eligibility criteria will be enrolled and randomized to receive either active drug or matching placebo. After a two-month, non-treatment period, patients will receive study drug for 6 months and will record information about sexual encounters in a daily diary. Study drug will be applied directly to the genital area 30-60 minutes before initiation of sexual activity. The endpoint of the study is based on the use of a standard measure of sexual function (FSEP).

Clinical Trial Description

This is a multicenter, double-blind, randomized, placebo-controlled, parallel-design study involving about 300 women who are 21-60 years of age inclusive, who have undergone a hysterectomy (with or without oophorectomy), and who have a primary diagnosis of FSAD. The diagnosis of FSAD will be made based on a medical and sexual history and confirmed using a structured interview by trained personnel. Study subjects will undergo a 2-month non-treatment run-in period followed by a 6-month period of blinded study therapy. Study drug is applied topically to the genitalia 30-60 minutes prior to initiation of sexual activity. Study subjects will complete several questionnaires at various times during the study and will complete a daily diary. The study endpoint is based on the FSEP and other standard questionnaires, as well as safety and tolerability of study drug. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

  • Sexual Dysfunction, Physiological
  • Sexual Dysfunctions, Psychological
Clinical Trial Details
NCT number NCT00324948
Study type Interventional
Source VIVUS, Inc.
Contact
Status Completed
Phase Phase 2
Start date September 2004
Completion date November 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT01021670 - An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride Phase 4
Recruiting NCT02624648 - Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women Phase 1
Completed NCT05692960 - Women's Interventions for Sexual Health: WISH N/A
Completed NCT01188720 - Sexual Health on Antidepressants Through Physical Exercise N/A
Completed NCT00692419 - Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients N/A
Completed NCT01063881 - The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy Phase 3
Completed NCT00451165 - Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery N/A
Recruiting NCT04604951 - Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury N/A
Recruiting NCT04512287 - PRP for Treatment of Peyronie's Disease Phase 2
Completed NCT02381912 - Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer N/A
Completed NCT00443248 - Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)). Phase 1
Completed NCT00443027 - Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women. Phase 1
Completed NCT00698035 - Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients Phase 2
Completed NCT03241524 - Consistency of Questionnaires to Evaluating Sexual Functions in Young Healthy Women N/A
Terminated NCT03018106 - Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction Phase 4
Completed NCT04364841 - Body Image and Sexuality After Bariatric Surgery
Completed NCT03592121 - Study to Investigate the Effect of AB-101 in Breast Cancer Survivors Early Phase 1
Completed NCT00482664 - The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder. Phase 2
Recruiting NCT05456919 - Quality of Sexual Function in BRCA Mutated Women
Recruiting NCT06308614 - Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women Phase 2